Margaret Haugh

UMC Utrecht, France

Poster(s):

• (A-339) 2024 interim results from the VAC4EU post-authorisation safety study (PASS) for the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) in Europe
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-338) Evaluating the Diagnostic Accuracy of Adverse Events of Special Interest Following Janssen COVID-19 Vaccine (JCOVDEN) Using the VAC4EU Validation Pipeline
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET